Synthesis, structures and ring-opening polymerization studies of new zinc chloride and amide complexes supported by amidinate heteroscorpionate ligands

Anti-EGFR conjugated nanoparticles to deliver Alpelisib as targeted therapy for head and neck cancer

Background

Head and neck squamous cell carcinoma (SCC) is one of the most prevalent and deadly cancers worldwide. Even though surgical approaches, radiation therapy, and therapeutic agents are commonly used, the prognosis of this cancer remains poor, with a tendency towards recurrence and metastasis. Current targeted therapeutic options for these patients are limited to monoclonal antibodies against EGFR or PD-1 receptors. Thus, there is an urgent need to introduce new molecularly targeted therapies for treating head and neck SCC. EGFR can be used as a target to improve the ability of nanoparticles to bind to tumor cells and deliver chemotherapeutic agents. In fact, over 90% of head and neck SCCs overexpress EGFR, and other tumor types, such as colorectal and glioblastoma, show EGFR overexpression. The PI3K/mTOR signaling pathway is one of the most commonly altered oncogenic pathways in head and neck SCC. Alpelisib is a specific PI3Kα inhibitor indicated for PIK3CA mutant advanced breast cancer that showed promising activity in clinical trials in head and neck SCC. However, its use is associated with dose-limiting toxicities and treatment-related adverse effects.

Results

We generated polylactide (PLA) polymeric nanoparticles conjugated to anti-EGFR antibodies via chemical cross-linking to a polyethyleneimine (PEI) coating. Antibody-conjugated nanoparticles (ACNP) displayed low polydispersity and high stability. In vivo, ACNP showed increased tropism for EGFR-expressing head and neck tumors in a xenograft model compared to non-conjugated nanoparticles (NP). Alpelisib-loaded nanoparticles were homogeneous, stable, and showed a sustained drug release profile. Encapsulated Alpelisib inhibited PI3K pathway activation in the different cell lines tested that included wild type and altered PIK3CA. Alpelisib-NP and Alpelisib-ACNP decreased by 25 times the half-maximal inhibitory concentration compared to the free drug and increased the bioavailability of the drug in the cells. Herein we propose an efficient strategy to treat head and neck SCC based on nanotechnology.

Conclusions

Anti-EGFR-conjugated polymeric nanoparticles are an effective delivery system to increase drug efficiency and bioavailability in head and neck cancer cells. This strategy can help reduce drug exposure in disease-free organs and decrease drug-associated unwanted side effects.

Catalytic, Z-Selective, Semi-Hydrogenation of Alkynes with a Zinc-Anilide Complex

The reversible activation of dihydrogen with a molecular zinc anilide complex is reported. The mechanism of this reaction has been probed through stoichiometric experiments and density functional theory (DFT) calculations. The combined evidence suggests that H₂ activation occurs by addition across the Zn-N bond via a four-membered transition state in which the Zn and N atoms play a dual role of Lewis acid and Lewis base. The zinc hydride complex that results from H₂ addition has been shown to be remarkably effective for the hydrozincation of C═C bonds at modest temperatures. The scope of hydrozincation includes alkynes, alkenes, and a 1,3-butadiyne. For alkynes, the hydrozincation step is stereospecific leading exclusively to the syn-isomer. Competition experiments show that the hydrozincation of alkynes is faster than the equivalent alkene substrates. These new discoveries have been used to develop a catalytic system for the semi-hydrogenation of alkynes. The catalytic scope includes both aryl- and alkyl-substituted internal alkynes and proceeds with high alkene: alkane, Z:E ratios, and modest functional group tolerance. This work offers a first example of selective hydrogenation catalysis using zinc complexes.

Zinc 8-aminotrihydroquinolines appended with pendant N-diphenylphosphinoethyl arms as exceptionally active catalysts for the ROP of ε-CL

Through activation with LiCH2SiMe3 or LiN(SiMe3)2, zinc(ii) chloride complexes bearing 5,6,7-trihydroquinolin-8-amines appended with pendant diphenyl phosphine units displayed remarkable catalytic activity for ROP of ε-caprolactone.

Mithramycin delivery systems to develop effective therapies in sarcomas

BACKGROUND

Sarcomas comprise a group of aggressive malignancies with very little treatment options beyond standard chemotherapy. Reposition of approved drugs represents an attractive approach to identify effective therapeutic compounds. One example is mithramycin (MTM), a natural antibiotic which has demonstrated a strong antitumour activity in several tumour types, including sarcomas. However, its widespread use in the clinic was limited by its poor toxicity profile.

RESULTS

In order to improve the therapeutic index of MTM, we have loaded MTM into newly developed nanocarrier formulations. First, polylactide (PLA) polymeric nanoparticles (NPs) were generated by nanoprecipitation. Also, liposomes (LIP) were prepared by ethanol injection and evaporation solvent method. Finally, MTM-loaded hydrogels (HG) were obtained by passive loading using a urea derivative non-peptidic hydrogelator. MTM-loaded NPs and LIP display optimal hydrodynamic radii between 80 and 105 nm with a very low polydispersity index (PdI) and encapsulation efficiencies (EE) of 92 and 30%, respectively. All formulations show a high stability and different release rates ranging from a fast release in HG (100% after 30 min) to more sustained release from NPs (100% after 24 h) and LIP (40% after 48 h). In vitro assays confirmed that all assayed MTM formulations retain the cytotoxic, anti-invasive and anti-stemness potential of free MTM in models of myxoid liposarcoma, undifferentiated pleomorphic sarcoma and chondrosarcoma. In addition, whole genome transcriptomic analysis evidenced the ability of MTM, both free and encapsulated, to act as a multi-repressor of several tumour-promoting pathways at once. Importantly, the treatment of mice bearing sarcoma xenografts showed that encapsulated MTM exhibited enhanced therapeutic effects and was better tolerated than free MTM.

CONCLUSIONS

Overall, these novel formulations may represent an efficient and safer MTM-delivering alternative for sarcoma treatment.

Efficient Bulky Organo-Zinc Scorpionates for the Stereoselective Production of Poly(rac-lactide)s

The direct reaction of the highly sterically demanding acetamidinate-based NNN'-scorpionate protioligand Hphbp^tamd [Hphbp^tamd = N,N'-di-p-tolylbis(3,5-di-tertbutylpyrazole-1-yl)acetamidine] with one equiv. of ZnMe₂ proceeds in high yield to the mononuclear alkyl zinc complex [ZnMe(κ³-phbp^tamd)] (1). Alternatively, the treatment of the corresponding lithium precursor [Li(phbp^tamd)(THF)] with ZnCl₂ yielded the halide complex [ZnCl(κ³-phbptamd)] (2). The X-ray crystal structure of 1 confirmed unambiguously a mononuclear entity in these complexes, with the zinc centre arranged with a pseudotetrahedral environment and the scorpionate ligand in a κ³-coordination mode. Interestingly, the inexpensive, low-toxic and easily prepared complexes 1 and 2 resulted in highly efficient catalysts for the ring-opening polymerisation of lactides, a sustainable bio-resourced process industrially demanded. Thus, complex 1 behaved as a single-component robust initiator for the living and immortal ROP of rac-lactide under very mild conditions after a few hours, reaching a TOF value up to 5520 h^-1 under bulk conditions. Preliminary kinetic studies revealed apparent zero-order dependence on monomer concentration in the absence of a cocatalyst. The PLA materials produced exhibited narrow dispersity values, good agreement between the experimental M_n values and monomer/benzyl alcohol ratios, as well as enhanced levels of heteroselectivity, reaching P_s values up to 0.74.

Magnesium, calcium and zinc [N2N'] heteroscorpionate complexes

A new family of sterically demanding N2N' heteroscorpionate pro-ligands (HC(tBu2pz)2SiMe2N(H)R (R = iPr, tBu, Ph, Xyl)) has been prepared via a straightforward modular synthetic route. An extensive study into the synthesis and characterisation of lithium, magnesium, calcium and zinc complexes supported by both 3,5-tBu and 3,5-Me substituted N2N' ligand families has been conducted. Attempted deprotonation of the pro-ligands with nBuLi afforded the corresponding lithium salts Li{HC(tBu2pz)2SiMe2NR} (R = iPr (1), tBu (2), Ph (3) and Xyl (4)) but air- and thermal-sensitivity limited the yields of these potentially useful precursors; only the sterically encumbered ligand system allowed clean reactivity. Magnesium methyl complexes Mg{HC(tBu2pz)2SiMe2NR}Me (R = iPr (5) and R = Ph (6)) were prepared using an excess of the Grignard reagent MeMgCl. Magnesium butyl complexes were synthesised in good yields using the dialkyl precursor MgnBu2 to afford Mg{HC(R'2pz)2SiMe2NR}nBu (R' = Me; R = iPr (7), tBu (8), Ad (9), Ph (10). R' = tBu; R = iPr (11), Ph (12)). Protonolylsis reactions were used to synthesise magnesium and calcium amide complexes Mg{HC(R'2pz)2SiMe2NR}{N(SiHMe2)2} (R' = Me; R = iPr (13), tBu (14), Ph (15). R' = tBu; R = Ph (16)) or Mg{HC(R'2pz)2SiMe2NR}{N(SiMe3)2} (R' = Me; R = iPr (17), tBu (18), Ph (19). R' = tBu; R = Ph (20)), and Ca{HC(R'2pz)2SiMe2NR}{N(SiMe2)2} (L) (R' = Me; L = thf; R = iPr (21), tBu (22), Ph (23). R' = tBu; L = none; R = Ph (24). Zinc methyl complexes Zn{HC(R'2pz)2SiMe2NR}Me (R' = Me; R = iPr (25), tBu (26), Ph (27). R' = tBu; R = Ph (28)) were prepared by reaction of the N2N' heteroscorpionate pro-ligands with ZnMe2. In preliminary studies, magnesium amide complexes 16 and 20 were evaluated as initiators for the ring-opening polymerisation (ROP) of ε-caprolactone (ε-CL) and rac-lactide (rac-LA). Although the overall polymerisation control was poor, 16 and 20 were found to be active initiators.

Multiple coordination modes of a new ditopic bis(pyrazolyl)methane-based ligand

A new ditopic ligand, N-(2,2-bis(pyrazolyl)ethyl)-2,2-bis(pyrazolyl)acetamide ((pz)₂CH-C(O)-NH-CH₂-CH(pz)₂, L4Pz, pz = pyrazolyl ring), comprising two bis(pyrazolyl)methane donor groups linked via an amide bridge, has been prepared from the reaction of HOOCCH(pz)₂ and H₂NCH₂CH(pz)₂. The ligand coordinates to various metallic salts (i.e. AgO₃SCF₃, PdCl₂, Re(CO)₅Br, and Fe(BF₄)₂), in either a κ²-μ-κ² or a κ³-μ-κ² fashion, depending on the coordination preferences of the metallic center. These compounds were characterized by NMR, UV-Vis and IR spectroscopy, and in solid state by single crystal X-ray diffraction. In the case of silver(i), a mono-dimensional coordination polymer was obtained, while the others were found to be discrete complexes. The synthesis and characterization of a heterobimetallic complex is also described. In solid state, all compounds are associated into supramolecular architectures via hydrogen bonding and pyrazolyl embrace interactions.

Simple ZnEt2as a catalyst in carbodiimide hydroalkynylation: structural and mechanistic studies

Simple ZnEt₂is an efficient catalyst for the addition of terminal alkynes to carbodiimides, through amidinate complexes, and consecutive isocyanate addition and intramolecular cyclohydroamination.

Zn(ii) and Cu(ii) formamidine complexes: structural, kinetics and polymer tacticity studies in the ring-opening polymerization of ε-caprolactone and lactides

The flexibility of ligands and their coordination chemistry with metal centers provided effective catalysts in the ring opening polymerization of cyclic esters.

Catalytic behaviour in the ring-opening polymerisation of organoaluminiums supported by bulky heteroscorpionate ligands

A series of alkyl organoaluminium complexes based on bulky heteroscorpionate ligands were designed as catalysts for the ring-opening polymerisation of cyclic esters. Thus, the treatment of AlX3 (X = Me, Et) with bulky acetamide or thioacetamide heteroscorpionate ligands nbptamH (1) [nbptamH = N-naphthyl-2,2-bis(3,5-dimethylpyrazol-1-yl)thioacetamide], fbpamH (2) [fbpamH = N-fluorenyl-2,2-bis(3,5-dimethylpyrazol-1-yl)acetamide], ptbptamH (3) [ptbptamH = N-phenyl-2,2-bis(3,5-di-tert-butylpyrazol-1-yl)thioacetamide], ntbptamH (4) [ntbptamH = N-naphthyl-2,2-bis(3,5-di-tert-butylpyrazol-1-yl)thioacetamide], ptbpamH (5) [ptbpamH = N-phenyl-2,2-bis(3,5-di-tert-butylpyrazol-1-yl)acetamide] and (S)-mtbpamH (6) [(S)-mtbpamH = (S)-(−)-N-α-methylbenzyl-2,2-bis(3,5-di-tert-butylpyrazol-1-yl)acetamide] for 1 hour at 0 °C afforded the dialkyl aluminium complexes [AlX2{κ(2)-nbptam}] (X = Me 7, Et 8), [AlX2{κ(2)-fbpam}] (X = Me 9, Et 10), [AlX2{κ(2)-ptbptam}] (X = Me 11, Et 12), [AlX2{κ(2)-ntbptam}] (X = Me 13, Et 14), [AlX2{κ2(-)ptbpam}] (X = Me 15, Et 16) and [AlX2{κ(2)-(S)-mtbpam}] (X = Me 17, Et 18). The structures of the complexes were determined by spectroscopic methods and the X-ray crystal structure of 14 was also established. The alkyl-containing aluminium complexes 7–18 can act as efficient single-component initiators for the ring-opening polymerisation of ε-caprolactone and rac-lactide. The polymerisations are living, as evidenced by the narrow polydispersities of the isolated polymers and the linear nature of the number average molecular weight versus conversion plot. Finally, a comparative study of ring-opening polymerisation for new bulky heteroscorpionate aluminium initiators and the less congested aluminium analogues is reported.

Enantiopure N,N,O-scorpionate zinc amide and chloride complexes as efficient initiators for the heteroselective ROP of cyclic esters

Amide-containing zinc heteroscorpionates can act as single-component initiators for the well-controlled ROP of rac-LA to produce heterotactic-enriched materials.